Skip to main content
VIKAS LIFECARE LIMITED logo

VIKAS LIFECARE LIMITED — Investor Relations & Filings

Ticker · VIKASLIFE ISIN · INE161L01027 LEI · 9845008856U9D9DABE98 BSE.NS Manufacturing
Open in API
Filings indexed 504 across all filing types
Latest filing 2024-12-31 Regulatory Filings
Country IN India
Listing BSE.NS VIKASLIFE

About VIKAS LIFECARE LIMITED

https://www.vikaslifecarelimited.com

Vikas Lifecare Limited is a diversified enterprise specializing in the manufacturing and trading of polymer and rubber compounds, specialty additives, and chemicals. The company produces high-performance polymer compounds utilized in sectors such as footwear, automotive, and infrastructure. Beyond its core chemical business, it has expanded into the Fast-Moving Consumer Goods (FMCG) and agro-products markets, focusing on the processing and distribution of premium food products. The company also provides infrastructure solutions, specifically in the domain of smart gas metering. A key aspect of its operations is the integration of recycled materials into its production cycles, reflecting a commitment to sustainable manufacturing. Its strategic focus involves vertical integration and portfolio diversification to address evolving industrial and consumer demands.

Recent filings

Filing Released Lang Actions
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to stock exchanges (NSE and BSE) regarding the closure of the trading window in compliance with SEBI regulations on insider trading. It specifies the period during which trading in the company's securities is prohibited due to the upcoming announcement of quarterly financial results. The document does not contain any financial data, results, or detailed report content but is an announcement related to trading restrictions ahead of financial disclosures. The document length is short (1976 characters), and it serves as a notification rather than a report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance-related communications that do not fit other categories.
2024-12-31 English
General Updates
Regulatory Filings Classification · 95% confidence The document is an intimation letter addressed to the Listing Compliance Departments of NSE and BSE, regarding the dispatch of the Notice of Postal Ballot and submission of related newspaper advertisements. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. The content focuses on the announcement of dispatch and publication of the Notice of Postal Ballot and e-voting information, not the actual Notice or results themselves. The document is about informing the stock exchanges about the dispatch and advertisement, which is a regulatory announcement rather than the report or voting results. It does not contain financial statements, voting results, or detailed meeting materials. Therefore, it fits best under Regulatory Filings (RNS) as a general compliance announcement.
2024-12-23 English
Shareholders meeting
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed notice of a Postal Ballot issued by Vikas Lifecare Limited, addressed to stock exchanges and shareholders. It includes information about the resolutions to be passed via postal ballot, including raising funds through issuance of securities, increasing authorized share capital, and appointment of a director. The document references SEBI regulations and the Companies Act, and details the e-voting process and timeline. It is not a report of voting results, but a notice seeking shareholder approval through postal ballot. It is also not a full financial report, earnings release, or management discussion. The primary purpose is to inform shareholders and regulatory bodies about the postal ballot and the business items to be voted on remotely. Therefore, the document fits the category of Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings or ballots.
2024-12-20 English
Outcome of Board Meeting
Capital/Financing Update Classification · 95% confidence The document is a formal communication addressed to stock exchanges regarding the outcome of a Board Meeting held on December 20, 2024. It details decisions made by the Board, including approval for raising funds through issuance of securities, increase in authorized capital, and seeking members' approval through postal ballot. The document is a notification of corporate actions and decisions taken by the Board rather than a full report or financial statement. It does not contain financial data or detailed analysis but rather announces board resolutions and upcoming shareholder voting procedures. Therefore, it fits the category of Capital/Financing Update (CAP) as it relates to fundraising and capital structure changes.
2024-12-20 English
Board Meeting — Other business matters
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to the stock exchanges (NSE and BSE) informing them about a scheduled Board Meeting on December 20, 2024. The letter mentions the agenda items such as issuance of securities and amendment of the Capital Clause, but it does not contain any financial data, results, or detailed report. The document is short (2664 characters) and serves as an announcement of an upcoming board meeting rather than the meeting materials or outcomes. It is not a full report, audit, or financial statement. Therefore, it fits the category of a Regulatory Filing (RNS) as a general regulatory announcement about a board meeting and related compliance information.
2024-12-17 English
General Updates
Regulatory Filings Classification · 95% confidence The document is a media release announcing that Vikas Lifecare Limited has signed a Technology Transfer Agreement with Advanced System Laboratory (ASL), DRDO for biodegradable plastics technology. It is addressed to the stock exchanges (NSE and BSE) under SEBI regulations and provides details about the agreement, the company's business, and strategic direction. There are no financial statements, quarterly or annual results, or detailed financial data. The document is a corporate announcement about a business development, not a financial report or regulatory filing. It is not a report publication announcement since it contains substantive information about the agreement itself. Therefore, the document fits best under the category of a Regulatory Filing (RNS) as a general regulatory announcement that does not fit other specific categories.
2024-12-16 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.